We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+12.14%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$12.6M
Cap. Flow
+$4.58M
Cap. Flow %
3.53%
Top 10 Hldgs %
72.64%
Holding
24
New
–
Increased
13
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
VICR icon
Vicor
VICR
+$1.3M
2
MOS icon
The Mosaic Company
MOS
+$1.2M
3
SLB icon
SLB Ltd
SLB
+$746K
4
NEM icon
Newmont
NEM
+$726K
5
HES
Hess
HES
+$611K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$442K
2
CI icon
Cigna
CI
+$403K
3
LHX icon
L3Harris
LHX
+$345K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$330K
5
MDT icon
Medtronic
MDT
+$302K

Sector Composition

Rank Sector Weight
1 Materials 19.66%
2 Energy 17.93%
3 Healthcare 17.75%
4 Utilities 15.02%
5 Technology 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VST icon
1
Vistra
VST
$54.7B
$19.5M 15.02%
100,450
+3,550
+4% +$525K
HES
2
DELISTED
Hess
HES
$12.6M 9.72%
90,925
+4,525
+5% +$611K
NEM icon
3
Newmont
NEM
$98.7B
$11.6M 8.96%
199,350
+13,600
+7% +$726K
VICR icon
4
Vicor
VICR
$9.79B
$10.4M 8.06%
230,200
+29,200
+15% +$1.3M
MOS icon
5
The Mosaic Company
MOS
$6.98B
$8.32M 6.42%
228,000
+37,475
+20% +$1.2M
CVS icon
6
CVS Health
CVS
$141B
$7.13M 5.5%
103,342
+242
+0.2% +$15.9K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$6.73M 5.19%
38,175
+2,400
+7% +$393K
AR icon
8
Antero Resources
AR
$10.5B
$6.57M 5.07%
163,000
+11,000
+7% +$417K
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$5.74M 4.43%
124,000
-9,000
-7% -$442K
NTR icon
10
Nutrien
NTR
$32.1B
$5.55M 4.28%
94,500
+5,500
+6% +$311K
CMCSA icon
11
Comcast
CMCSA
$85.1B
$3.95M 3.05%
110,725
+6,225
+6% +$215K
BG icon
12
Bunge Global
BG
$23.6B
$3.93M 3.04%
49,000
+1,000
+2% +$78.7K
SLB icon
13
SLB Ltd
SLB
$69.7B
$3.82M 2.95%
112,000
+21,500
+24% +$746K
QCOM icon
14
Qualcomm
QCOM
$183B
$3.74M 2.89%
23,500
+1,250
+6% +$184K
IP icon
15
International Paper
IP
$19.2B
$3.73M 2.88%
79,750
-1,500
-2% -$70.9K
CI icon
16
Cigna
CI
$76.8B
$3.6M 2.78%
10,900
-1,250
-10% -$403K
LHX icon
17
L3Harris
LHX
$51.7B
$3.51M 2.71%
14,000
-1,500
-10% -$345K
ABBV icon
18
AbbVie
ABBV
$452B
$3.43M 2.65%
18,500
– –
MDT icon
19
Medtronic
MDT
$105B
$3.1M 2.39%
35,240
-3,560
-9% -$302K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.7M 1.31%
3,500
-650
-16% -$330K
JPM icon
21
JPMorgan Chase
JPM
$918B
$435K 0.34%
1,500
– –
CVX icon
22
Chevron
CVX
$381B
$260K 0.2%
1,818
– –
AAPL icon
23
Apple
AAPL
$4.81T
$236K 0.18%
1,150
– –
PG icon
24
Procter & Gamble
PG
$345B
– –
-1,500
Closed -$256K

Similar funds

NAM
NewGen Asset Management Toronto, Ontario, Canada $259M AUM 140.76% 1-Year Est. Return
CCAM
Codex Capital Asset Management Dallas, Texas $259M AUM 32.71% 1-Year Est. Return
QP
Quartz Partners Saratoga Springs, New York $259M AUM 26.69% 1-Year Est. Return
BFA
Bluestem Financial Advisors Champaign, Illinois $259M AUM 12.01% 1-Year Est. Return
PW
Potentia Wealth San Jose, California $259M AUM 19.98% 1-Year Est. Return
BFP
Beacon Financial Planning Hyannis, Massachusetts $258M AUM 16.1% 1-Year Est. Return
TC
Toews Corporation Northfield, New Jersey $259M AUM 5.15% 1-Year Est. Return
FC
Financial Council Towson, Maryland $259M AUM 21.02% 1-Year Est. Return

Colrain Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Colrain Capital held 24 positions worth $130M, up 11% from $117M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Colrain Capital deployed $4.58M of net new capital in Q2 2025, adding to 13 existing holdings.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 16% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $442K trimmed.

  • Colrain Capital added most to Vicor in Q2 2025, an estimated $1.3M increase.
  • Colrain Capital's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $442K.
  • Colrain Capital fully exited Procter & Gamble in Q2 2025, selling an estimated $256K.
  • Colrain Capital's ten largest holdings make up 73% of its $130M portfolio in Q2 2025.
  • Colrain Capital opened 0 new positions and closed 1 in Q2 2025.
  • Colrain Capital's portfolio value rose 11% quarter-over-quarter to $130M.

Based on Colrain Capital's 13F filing for Q2 2025, filed 5 Aug 2025.